Cargando…
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001251/ https://www.ncbi.nlm.nih.gov/pubmed/35429443 http://dx.doi.org/10.1016/j.ccell.2022.04.003 |
| _version_ | 1784685630153818112 |
|---|---|
| author | Mair, Maximilian J. Mitterer, Manfred Gattinger, Pia Berger, Julia M. Trutschnig, Wolfgang Bathke, Arne C. Gansterer, Margaretha Berghoff, Anna S. Laengle, Severin Gottmann, Lynn Buratti, Thomas Haslacher, Helmuth Lamm, Wolfgang W. Raderer, Markus Tobudic, Selma Fuereder, Thorsten Valenta, Rudolf Fong, Dominic Preusser, Matthias |
| author_facet | Mair, Maximilian J. Mitterer, Manfred Gattinger, Pia Berger, Julia M. Trutschnig, Wolfgang Bathke, Arne C. Gansterer, Margaretha Berghoff, Anna S. Laengle, Severin Gottmann, Lynn Buratti, Thomas Haslacher, Helmuth Lamm, Wolfgang W. Raderer, Markus Tobudic, Selma Fuereder, Thorsten Valenta, Rudolf Fong, Dominic Preusser, Matthias |
| author_sort | Mair, Maximilian J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9001251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90012512022-04-12 Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron Mair, Maximilian J. Mitterer, Manfred Gattinger, Pia Berger, Julia M. Trutschnig, Wolfgang Bathke, Arne C. Gansterer, Margaretha Berghoff, Anna S. Laengle, Severin Gottmann, Lynn Buratti, Thomas Haslacher, Helmuth Lamm, Wolfgang W. Raderer, Markus Tobudic, Selma Fuereder, Thorsten Valenta, Rudolf Fong, Dominic Preusser, Matthias Cancer Cell Letter Elsevier Inc. 2022-05-09 2022-04-12 /pmc/articles/PMC9001251/ /pubmed/35429443 http://dx.doi.org/10.1016/j.ccell.2022.04.003 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Mair, Maximilian J. Mitterer, Manfred Gattinger, Pia Berger, Julia M. Trutschnig, Wolfgang Bathke, Arne C. Gansterer, Margaretha Berghoff, Anna S. Laengle, Severin Gottmann, Lynn Buratti, Thomas Haslacher, Helmuth Lamm, Wolfgang W. Raderer, Markus Tobudic, Selma Fuereder, Thorsten Valenta, Rudolf Fong, Dominic Preusser, Matthias Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron |
| title | Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron |
| title_full | Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron |
| title_fullStr | Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron |
| title_full_unstemmed | Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron |
| title_short | Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron |
| title_sort | enhanced sars-cov-2 breakthrough infections in patients with hematologic and solid cancers due to omicron |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001251/ https://www.ncbi.nlm.nih.gov/pubmed/35429443 http://dx.doi.org/10.1016/j.ccell.2022.04.003 |
| work_keys_str_mv | AT mairmaximilianj enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT mitterermanfred enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT gattingerpia enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT bergerjuliam enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT trutschnigwolfgang enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT bathkearnec enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT gansterermargaretha enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT berghoffannas enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT laengleseverin enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT gottmannlynn enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT burattithomas enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT haslacherhelmuth enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT lammwolfgangw enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT raderermarkus enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT tobudicselma enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT fuerederthorsten enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT valentarudolf enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT fongdominic enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron AT preussermatthias enhancedsarscov2breakthroughinfectionsinpatientswithhematologicandsolidcancersduetoomicron |